2m 2m 2m 2m 2m 2m 2m
ADVANCED BIOMED (ADVB)
NASDAQ
$2.36+$0.04 (+1.51%)
Price as of Nov 12, 2026 9:04 AM EST- $3.8MMarket Cap
- -74.34%1-Year Change
- Diagnostics & ResearchIndustry
ADVANCED BIOMED (ADVB)
$2.36+$0.04 (+1.51%)
ADVB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.32 | ||
Change | +$0.21 (+9.95%) | ||
Open | $2.12 | ||
High | $2.45 | ||
Low | $2.10 | ||
Previous Close | $2.11 | ||
Volume | 19,722 | ||
30-Day Average Volume | 35,944 | ||
1-Week Change | 10.48% | ||
1-Month Change | -56.31% | ||
1-Year Change | -74.34% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 1.7M | ||
Total Assets | $10.6M | ||
Market Cap | $3.8M | ||
Enterprise Value | $1.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$488,942.00 | ||
Free Cash Flow | N/A | ||
EBIT | -$488,830.00 | ||
EBITDA | -$479,504.00 | ||
Net Working Capital | N/A | ||
EPS | -$0.38 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | -6 | ||
PEG | 0 | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 02/20/2026 | ||
Earnings & Revenue